#166: The Need for Menopause and Longevity Solutions with Femgevity

This episode is sponsored by New Leaf Hyperbaric Oxygen Therapy - oxygen therapy that’s non-invasive treatment that strengthens your body from the inside out. In this episode, certified nurse midwife, Kristin Mallon, discusses the need for solutions in menopause, perimenopause, and hormonal changes associated with aging.  She explains how she and her business partner started Femgevity to address this need, as there were very few practitioners specializing in menopause care. They use laboratory data and diagnostic tools to provide personalized solutions for women. Kristin also shares her passion for longevity and her fear of death, which led her to explore ways to prevent aging and maintain a high quality of life in older age. Looking for something specific? Here you go! 00:01:48 Women's health and longevity.  00:08:20 Longevity medicine aims to extend both lifespan and healthspan.  00:26:47 Hormone replacement therapy controversy.  00:37:47 Comprehensive testing for menopause management.  00:43:09 Precision medicine testing for menopause. About Femgevity:  Michele Wispelwey, MBA, is the Co-Founder and President of FemGevity, a digital telehealth platform service that emphasizes the commitment to servicing women 40+ through precision medicine for menopause and longevity. FemGevity leverages healthcare achievements to establish integrated health services for menopause guidance to advance women’s life spans. Michele's early career in the clinical and life sciences sector sparked her realization of the need for creating women's health programs across prominent laboratories regionally, and she has since positioned herself for success across top-ranked institutions, including Labcorp and Quest Diagnostics. She is a sought-after resource, mentor, and strategist for healthcare leaders, and her expertise in healthcare management and marketing has enabled her to drive change and modernize programs. Michele is committed to continuing her education and leveraging her knowledge to advance the femtech and digital healthcare industry. Kristin Mallon, CNM, MS, RNC-OB, is a board-certified nurse midwife, menopause, and feminine longevity expert, breast health expert, published author, and mother of four. She graduated from the University of California, Berkeley with a degree in Psychology and completed her Bachelor's degree in nursing at Johns Hopkins in Baltimore, MD. After completing her Master's degree in Science & Midwifery at New York University (NYU), she began practicing as a board-certified nurse midwife in private practice in Brooklyn, NY. In 2022, she co-founded Femgevity, a telemedicine company focused on menopause and feminine longevity, providing concierge care for women seeking personalized healthcare. As a California native, Kristin loves surf, snow, and hanging with her family in northern New Jersey. Find the both at the following links: www.femgevityhealth.com Instagram: @femgevity Facebook: www.facebook.com/FemGevity Our Advice! Everything in this podcast is for educational purposes only. It does not constitute the practice of medicine and we are not providing medical advice. No Physician-patient relationship is formed and anything discussed in this podcast does not represent the views of our employers.  The Fine Print! All opinions expressed by the hosts or  guests in this episode are solely their opinion and are not to be used as specific medical advice.  The hosts,  May and Tim Hindmarsh MD, BS Free MD LLC, or any affiliates thereof are not under any obligation to update or correct any information provided in this episode. The guest's statements and opinions are subject to change without notice. Thanks for joining us! You are the reason we are here.  If you have questions, reach out to us at [email protected] or find Tim and I on Facebook and IG. Please check out our every growing website as well at  bsfreemd.com (no www)  GET SOCIAL WITH US! https://www.withkoji.com/@bsfreemd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.